ABO-Rh Prenatal
Also known as: ABORH-PR
Use
This test is used to determine the patient's blood type (ABO and Rh D) in prenatal patients to evaluate possible risk for hemolytic disease of the fetus and newborn (HDFN) and to assess if the patient is a candidate for Rh Immunoglobulin.
Special Instructions
Not provided.
Limitations
This test is limited to assessing the ABO and Rh D antigen status. Variants that do not result in hemagglutination may not be detected. Interfering substances or improper handling may lead to inaccurate results. Repeat testing or alternative methods may be required for inconclusive results.
FDA ApprovedNew York Approved
Methodology
Other
Biomarkers
LOINC Codes
- 882-1 - ABO + Rh Bld
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
7 mL
Minimum Volume
3 mL
Container
Lavender (K2EDTA) or Pink (K2EDTA)
Storage Instructions
Transport refrigerated.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Unacceptable |
| Refrigerated | 1 week |
| Frozen | Unacceptable |
Other tests from different labs that may be relevant